Literature DB >> 16452125

Aggregate formation and phosphorylation of neurofilament-L Pro22 Charcot-Marie-Tooth disease mutants.

Takahiro Sasaki1, Takahiro Gotow, Motoko Shiozaki, Fumika Sakaue, Taro Saito, Jean-Pierre Julien, Yasuo Uchiyama, Shin-Ichi Hisanaga.   

Abstract

Charcot-Marie-Tooth disease (CMT) is the most common inherited peripheral nerve disorder. The causative gene for axonal type CMT2E has been identified as neurofilament light (NF-L) chain. Using cultured cells and in vitro assays, we analyzed the filament formation ability of Pro22 CMT mutant proteins of NF-L, P22S and P22T. NF-L Pro22 mutant proteins formed large aggregates in SW13- cells and cortical neurons and assembled into short twisty threads thinner than 10 nm filaments in vitro. Those threads associated with each other at their ends and entangled into large aggregates, also abnormalities, were detected at steps in oligomer formation. Pro22 mutations abolished Thr21 phosphorylation by cyclin-dependent kinase 5 and external signal regulated kinase, which suppressed filament assembly, but phosphorylation by protein kinase A (PKA) inhibited aggregate formation in vitro and alleviated aggregates in cortical neurons. These results indicate that the Pro22 CMT mutation induces abnormal filament aggregates by disrupting proper oligomer formation and the aggregates are mitigated by phosphorylation with PKA, which makes it a viable target for the development for therapeutics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452125     DOI: 10.1093/hmg/ddl011

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  26 in total

1.  Peripherin is a subunit of peripheral nerve neurofilaments: implications for differential vulnerability of CNS and peripheral nervous system axons.

Authors:  Aidong Yuan; Takahiro Sasaki; Asok Kumar; Corrinne M Peterhoff; Mala V Rao; Ronald K Liem; Jean-Pierre Julien; Ralph A Nixon
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

Review 2.  Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments.

Authors:  Ram K Sihag; Masaki Inagaki; Tomoya Yamaguchi; Thomas B Shea; Harish C Pant
Journal:  Exp Cell Res       Date:  2007-04-12       Impact factor: 3.905

Review 3.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

Review 4.  Neurofilaments at a glance.

Authors:  Aidong Yuan; Mala V Rao; Ralph A Nixon
Journal:  J Cell Sci       Date:  2012-07-15       Impact factor: 5.285

Review 5.  Neurofilaments and Neurofilament Proteins in Health and Disease.

Authors:  Aidong Yuan; Mala V Rao; Ralph A Nixon
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-04-03       Impact factor: 10.005

Review 6.  Intermediate Charcot-Marie-Tooth disease.

Authors:  Lei Liu; Ruxu Zhang
Journal:  Neurosci Bull       Date:  2014-10-17       Impact factor: 5.203

7.  MSC p43 required for axonal development in motor neurons.

Authors:  Xiaodong Zhu; Yang Liu; Yanqing Yin; Aiyun Shao; Bo Zhang; Sunghoon Kim; Jiawei Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

Review 8.  Role of dichloroacetate in the treatment of genetic mitochondrial diseases.

Authors:  Peter W Stacpoole; Tracie L Kurtz; Zongchao Han; Taimour Langaee
Journal:  Adv Drug Deliv Rev       Date:  2008-07-04       Impact factor: 15.470

9.  Neurofilaments form a highly stable stationary cytoskeleton after reaching a critical level in axons.

Authors:  Aidong Yuan; Takahiro Sasaki; Mala V Rao; Asok Kumar; Vivek Kanumuri; David S Dunlop; Ronald K Liem; Ralph A Nixon
Journal:  J Neurosci       Date:  2009-09-09       Impact factor: 6.167

10.  NEFL Pro22Arg mutation in Charcot-Marie-Tooth disease type 1.

Authors:  Ji Soo Shin; Ki Wha Chung; Sun Young Cho; Jiyoung Yun; Su Jin Hwang; Sung Hee Kang; En Min Cho; Seung-Min Kim; Byung-Ok Choi
Journal:  J Hum Genet       Date:  2008-08-29       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.